Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Department of Health and Human Services (HHS)
Research
MIT rejects Trump deal tying research money to certain demands
MIT has refused the Trump administration’s offer for prioritized funding if it complies with a set of demands—the first university to publicly do so.
Gabrielle Masson
Oct 10, 2025 1:12pm
ARPA-H goes all in on in vivo cell therapy
Oct 8, 2025 4:04pm
Big pharma cuts and gene therapy woes: Inside Q3's layoffs
Oct 3, 2025 4:30pm
White House pledges $100M to AI pediatric cancer project
Oct 1, 2025 11:06am
Dana-Farber oncologist Anthony Letai tapped to direct NCI
Sep 30, 2025 5:50am
HHS division refers Harvard for potential debarment
Sep 29, 2025 4:59pm
